CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY (REMS) PROGRAM

PLEASE NOTE: All providers and pharmacies that prescribe or dispense clozapine must re-certify in the Clozapine Risk Evaluation and Mitigation Strategy (REMS) program by November 15, 2021. Prescribers and pharmacies that fail to re-certify cannot prescribe or dispense clozapine. To avoid disruption in care, prescribers must also re-enroll their patients in the Clozapine REMS program by November 15, 2021.To view the full memorandum, click here.

last updated: October 22, 2021

Ready to Join Us?

Talk to us about questions or concerns

Monday–Saturday | 8 am–8 pm (ET)

Already A Member?

Log into the Member Portal

See Plan information, Health Rewards, and Messages

Speak To Someone In Your Community

Find someone in your neighborhood and in your language